Forum Πρωτοβάθμιας Φροντίδας Υγείας
ΠΦΥ -Εκπαίδευση => Αποσπάσματα από τον έντυπο & ηλεκτρονικό τύπο => Μήνυμα ξεκίνησε από: Argirios Argiriou στις 3 Φεβρουαρίου 2020, 21:23:18
-
Läkartidningen, 29-01-2020
The anti-diarrheal drug loperamide is a mu-opioid agonist with poor systemic bioavailability at standard doses. However, at very high doses bioavailability increases, due to saturation of P-glycoprotein and first-pass metabolism, leading both to opioid effects on the central nervous system and possible systemic side effects. There have been several reports in the literature recently regarding life-threatening cardiovascular symptoms after longstanding daily intake of massive loperamide doses. We hereby describe a patient with syncope who displayed wide QRS complexes and prolonged QTc intervals on ECG upon arrival to hospital. The patient developed typical bursts of torsade de pointes during a prolonged hospital course.
http://www.lakartidningen.se/Klinik-och-vetenskap/Fallbeskrivning/2020/01/Livsfarligt-missbruk-av-receptfria-diarrelakemedlet-loperamid/ (http://www.lakartidningen.se/Klinik-och-vetenskap/Fallbeskrivning/2020/01/Livsfarligt-missbruk-av-receptfria-diarrelakemedlet-loperamid/)